Full Text
EE302 Cost-Utility Analysis of Eptinezumab Versus Erenumab for Episodic Migraine Headaches Patients in the United States

Abstract

Authors

W Dong M Bounthavong

Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×